Laura Escudero
Hamilton, ON L8S4L8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell function.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 17, 2026
A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis.
Journal: Science translational medicine
Published: July 02, 2025
Using GlioVis to Explore, Analyze, and Visualize Brain Tumor Multi-Omics Datasets.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 24, 2025
Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment Resistance.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 02, 2024
De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases.
Journal: Cell reports. Medicine
Published: December 11, 2023
Intratumoral Delivery of Chimeric Antigen Receptor T Cells Targeting CD133 Effectively Treats Brain Metastases.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2023
Cancer-selective metabolic vulnerabilities in MYC-amplified medulloblastoma.
Journal: Cancer cell
Published: June 26, 2022
Cerebrospinal fluid liquid biopsies for medulloblastoma.
Journal: Nature reviews. Clinical oncology
Published: December 16, 2021
ctDNA-Based Liquid Biopsy of Cerebrospinal Fluid in Brain Cancer.
Journal: Cancers
Published: March 22, 2021
Cerebrospinal fluid circulating tumour DNA as a liquid biopsy for central nervous system malignancies.
Journal: Current opinion in neurology
Published: November 12, 2020
Last Updated: 09/26/2026